White label ELPA - ClinicalTrials.eu

Study Comparing Subcutaneous and Intravenous Paracetamol for Pain Relief in Adult Palliative Care Patients

Not yet recruiting

4 1 1 1
Investigated drugs:
- Paracetamol
Study on the Effectiveness of Valganciclovir for Patients with Glioblastoma

Not yet recruiting

2 1 1
Investigated diseases:
- Glioblastoma multiforme
Investigated drugs:
- Valganciclovir
Study of Durvalumab, Cisplatin, Carboplatin, and Etoposide for Patients with Extensive Stage Small Cell Lung Cancer

Not yet recruiting

2 1 1 1
Investigated diseases:
- Small cell lung cancer extensive stage
- Small cell lung cancer metastatic
Investigated drugs:
Study on Daratumumab, Carfilzomib, Pomalidomide, and Dexamethasone for Patients with Multiple Myeloma and Acute Kidney Failure

Not yet recruiting

2 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
Study of LY3540378 for Adults with Worsening Chronic Heart Failure with Preserved Ejection Fraction

Not recruiting

2 1
Investigated drugs:
- Igg Against Serum Albumin Fused With Relaxin 2, Chain B (2-29) And Relaxin 2 (Chain A)
Study Comparing Axicabtagene Ciloleucel and Standard Treatment for Adults with High-Risk Large B-Cell Lymphoma

Not recruiting

3 1 1 1
Investigated diseases:
- Diffuse large B-cell lymphoma
Investigated drugs:
+1
Phase III Study of the Efficacy and Safety of Fenebrutinib Compared with Teriflunomide in Adult Patients with Relapsing Multiple Sclerosis

Not recruiting

3 1 1
Investigated drugs:
- Fenebrutinib
- Teriflunomide
+1
Baricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis

Not recruiting

3 1 1 1
Investigated drugs:
+9
Study on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis

Not recruiting

3 1 1
Investigated drugs:
- Fenebrutinib
- Teriflunomide
+1
Study of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations

Not recruiting

3 1 1 1
Investigated drugs:
+4

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies